Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Below is Validea's guru fundamental report for NOVO NORDISK A/S (ADR) (NVO). Of the 22 guru strategies we follow, NVO rates highest using our Patient Investor m...
Key Points Eli Lilly has arguably taken the lead in the obesity drug space. Novo Nordisk has struggled, but remains a top contender with a potential catalyst...
Novo Nordisk (NYSE:NVO) has recently seen its stock experience some pressure, with shares closing at $54.37. Over the past month, the stock has slid 7%, and ove...
Analyst ratings
59%
of 32 ratingsMore NVO News
(RTTNews) - Novo Nordisk announced that the US Food and Drug Administration has approved Rybelsus—the only oral GLP-1 medication—for reducing the risk of major...
Novo Nordisk has also submitted an application for its Wegovy drug to be approved for the treatment of obesity. mads claus rasmussen/Agence France-Presse/Getty...
Novo Nordisk (NVO) announced that the U.S. FDA has approved Rybelsus, the only oral GLP-1 medication available, for reducing the risk of major adverse cardiovas...
Key Points Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 we...
The weight-loss industry that fueled one of Wall Street’s most popular ETF themes may finally be going on a crash diet. ETFs loaded with exposure to obesity-dr...
Novo Nordisk A/S (NASDAQ:NVO) is back in the headlines, and not just for its blockbuster weight-loss drug, Ozempic. President Donald Trump recently suggested a...
Shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) are trading lower Friday morning, continuing an after-hours slide that began Thursday. The dec...
